Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Inactive · Last trade price on Jan 23, 2024

Orchard Therapeutics Analyst Ratings

Total Analysts
3
Consensus Rating
Buy
Price Target
$21.67
Upside
+29.76%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Stifel
Stifel
Hold
Downgrades
$16
Hold Downgrades $16 -4.19% Oct 5, 2023
Oppenheimer
Oppenheimer
Buy
Reiterates
$34
Buy Reiterates $34 +103.59% Aug 9, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$15
Buy Reiterates $15 -10.18% Jun 27, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$37$34
Buy Maintains $37$34 +103.59% Jun 13, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$3$15
Buy Maintains $3$15 -10.18% Mar 28, 2023
Barclays
Barclays
Buy
Maintains
$60$40
Buy Maintains $60$40 +139.52% May 13, 2022
SMBC Nikko
SMBC Nikko
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Apr 1, 2022
Cowen & Co.
Cowen & Co.
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Mar 31, 2022
JP Morgan
JP Morgan
Sell
Downgrades
n/a
Sell Downgrades n/a n/a Nov 16, 2021
Oppenheimer
Oppenheimer
Buy
Maintains
n/a
Buy Maintains n/a n/a Nov 5, 2021
JP Morgan
JP Morgan
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Aug 18, 2021
JP Morgan
JP Morgan
Buy
Initiates
n/a
Buy Initiates n/a n/a Mar 2, 2021
Oppenheimer
Oppenheimer
Buy
Maintains
n/a
Buy Maintains n/a n/a Apr 1, 2020
Cowen & Co.
Cowen & Co.
Buy
Initiates
n/a
Buy Initiates n/a n/a Nov 26, 2018